Black Hawk Acquisition Corporation Reports Q3 Financial Results and Business Combination Plans

Black Hawk Acquisition Corporation has reported its financial results for the three and nine months ended August 31, 2026, revealing a net income of $1,074,736 for the quarter, a significant increase from $154,401 in the same period last year. For the nine-month period, the company recorded a net income of $1,303,470, slightly down from $1,333,322 in the previous year. The increase in quarterly net income is attributed to a gain on debt forgiveness amounting to $1,015,988, alongside interest income of $230,184, which offset general and administrative expenses of $108,210 and related party administrative fees of $30,000.

In terms of operational metrics, Black Hawk's total assets increased to $26,034,667 as of August 31, 2026, compared to $23,877,939 at the end of the previous fiscal period. This growth was primarily driven by an increase in investments held in the Trust Account, which rose to $25,993,300 from $23,827,149. However, the company also reported a working capital deficit of $2,294,124, indicating potential liquidity challenges as it continues to seek a business combination.

Strategically, Black Hawk is in the process of completing a business combination with Vesicor Therapeutics, Inc., which has been valued at a pre-money equity value of $70 million. The transaction, which has received unanimous approval from both companies' boards, is expected to close in the fourth quarter of 2026, subject to regulatory approvals and shareholder consent. The company has also entered into various financing agreements with Meteora Select Trading Opportunities Master, LP, to support the business combination and has scheduled an extraordinary general meeting for shareholders on October 13, 2026, to discuss the proposed transaction.

Despite these developments, Black Hawk faces challenges, including a Nasdaq delisting notice received in March 2026 due to its market value falling below the required $50 million. The company successfully regained compliance by August 2026. Additionally, the company has incurred significant professional costs related to its public company status and the pursuit of its business combination, raising concerns about its ability to continue as a going concern if it fails to complete the transaction within the designated timeframe.

Looking ahead, Black Hawk's management has expressed uncertainty regarding its ability to consummate a business combination within the required period, which could lead to voluntary liquidation. The company has indicated that it will continue to seek additional capital to meet its liquidity needs and cover operational expenses as it navigates the complexities of finalizing its merger with Vesicor.